Foresight Medical is developing a device agnostic mobile application to accurately measure pupil reactions to light, which can be used as a potential biomarker for early Alzheimer's disease and dementia detection. Utilising advanced artificial intelligence and pupillometry, our low-cost, easily accessible application will provide users with valuable insights into their Alzheimer's risk profile. Foresight Medical seeks to empower citizens with greater health information and peace of mind, allowing individuals to take proactive measures and better preserve their mental health and well-being.

Alzheimer's disease is a growing global concern, and early detection is crucial for effective intervention. Our application will enable users to assess their risk factors affordably and make informed decisions about their lifestyle and proactively seek medical advice when necessary. Through encouraging widespread adoption, we aim to create a more health-conscious population. With user consent, the collected data will be anonymized and aggregated, offering valuable insights into Alzheimer's trends and prevalence. This information can aid health authorities in refining policies, allocating resources efficiently, and advancing scientific understanding of the disease.

Foresight Medical's mobile application aims to provide users and policy makers with crucial health information. We are working to contribute to the enhancement of the Western Australia health system in facilitating early detection and improved management of Alzheimer's disease.